Scinai Immunotherapeutics Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Scinai Immunotherapeutics Ltd's ROI in the fourth quarter of 2025?
Scinai Immunotherapeutics Ltd recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -98.45%.

Within the Healthcare sector 694 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 4232.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Investment Change TTM	-45.55 %	-43.47 %	-56.38 %	-50.96 %	-51.56 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	9	8	8	8	15
Return On Investment (TTM)	-98.45 %	64.91 %	55.85 %	19.74 %	-5.01 %
SCNI's Overall Ranking	# 4232	#	#	#	#
Seq. Investment Change TTM	-15.74 %	-13.96 %	-16.1 %	-10.48 %	-12.52 %
Seq. Net Income Change TTM	-	0 %	137.4 %	-	-
Net Income (TTM) in Millions	-8	7	7	3	-1

SCNI Company Profile >> Back to SCNI Roi Comparisons >> See Annual SCNI Return On Investment

Return On Investment SCNI's Ranking
Within:	No.
Industry	# 112
Sector	# 695
Overall	# 4232

Return On Investment Statistics
High	Average	Low
43.64 %	-27.64 %	-98.93 %
(Dec 31 2023)		(Dec 31 2025)

Financial Statements
Scinai Immunotherapeutics Ltd's IV. Quarter Investments	$ 9 Millions	SCNI's Balance sheet
Scinai Immunotherapeutics Ltd's IV. Quarter Income	$ -8 Millions	Quarterly SCNI's Income Statement
SCNI's Income by Division		See SCNI's Income by Division

SCNI Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2023) 2023
Total Investments in Millions	9	15	24	51	-13
Y / Y Investment Growth	-41.73 %	-36.99 %	-52.76 %	-	-
Net Income in Millions	-8	7	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-94.33 %	43.01 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SCNI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SCNI's Competitors
Subscribers only: Roi for Scinai Immunotherapeutics Ltd's Suppliers
Subscribers only: Return On Investment for SCNI's Customers

Other Ratios
SCNI's Roa	SCNI's Inventory Turnover Ratio	SCNI's Growth Rates	SCNI's Dividend Statistics
	SCNI's Profitability Ratios	SCNI's Asset Turnover Ratio	SCNI's Dividend Growth
SCNI's Roe	SCNI's Valuation Ratios	SCNI's Financial Strength Ratios	SCNI's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-07-07T13:25:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.